Legal & General Group PLC Ascendis Pharma A/S Transaction History
Legal & General Group PLC
- $368 Billion
- Q4 2024
A detailed history of Legal & General Group PLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Legal & General Group PLC holds 17,682 shares of ASND stock, worth $2.71 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,682
Previous 1,054
1577.61%
Holding current value
$2.71 Million
Previous $157,000
1450.32%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ASND
# of Institutions
236Shares Held
60.2MCall Options Held
80.3KPut Options Held
216K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.55 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$847 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$781 Million10.24% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.45MShares$682 Million0.98% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$671 Million0.32% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $8.55B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...